Skip to main content

Advertisement

SpringerLink
Log in

Melanoma survivorship: research opportunities

  • Published:
Journal of Cancer Survivorship: Research and Practice Aims and scope Submit manuscript

Abstract

Introduction

The rising incidence and mortality rates of melanoma, the most fatal form of skin cancer, are among the greatest increases of all preventable cancers over the past decade. However, because of recent advances in early detection, secondary prevention efforts, and treatment, the number of melanoma survivors is increasing. Little research has been conducted on melanoma survivors and important opportunities exist for research in this understudied population. Here, we outline the important research opportunities related to the study of melanoma survivorship and summarize the paucity of literature currently available.

Materials and methods

A computerized literature search was performed of the MEDLINE® database of the National Library of Medicine from 1966–2005. The scope of the search was limited to those studies published in English. The search was conducted using the following MeSH headings: melanoma, neoplasms, skin neoplasms, survival, and survival rate. The reference lists of relevant book chapters and review articles were further reviewed, and printed materials from recent scientific meetings addressing this topic were obtained.

Results

Several factors that affect melanoma survivors warrant further study, including: physiologic long-term effects; psychosocial, behavioral, and cognitive factors; demographic characteristics; surveillance practices; recurrences, secondary primaries, and other cancers; family members of survivors; and economic issues, access to health care/life insurance.

Conclusions

Understanding recurrence and second primary cancer risk, psychosocial and cognitive characteristics, behaviors, surveillance patterns, economic sequelae, and family issues of melanoma survivors is important from a public health standpoint to promote the health and well-being of this cohort.

Implications for cancer survivors

Melanoma is an understudied cancer, and the incidence and mortality of this disease are increasing. Describing the long term burden of this cancer and identifying factors that contribute to them will facilitate efforts to develop responsive secondary prevention strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aitchison, T. C., Sirel, J. M., Watt, D. C., & MacKie, R. M. (1995). Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group. British Medical Journal, 311(7019), 1536–1539; discussion 1539–1541.

    PubMed  CAS  Google Scholar 

  2. Aitken, J. F., Green, A. C., MacLennan, R., Youl, P., & Martin, N. G. (1996). The Queensland Familial Melanoma Project: Study design and characteristics of participants. Melanoma Research, 6(2), 155–165.

    PubMed  CAS  Google Scholar 

  3. American Cancer Society (2005). American cancer society: Cancer facts & figures 2005. Atlanta, GA: American Cancer Society.

    Google Scholar 

  4. Armstrong, B. K., & Kricker, A. (1993). How much melanoma is caused by sun exposure? Melanoma Research, 3(6), 395–401.

    PubMed  CAS  Google Scholar 

  5. Autier, P., & Dore. J. F. (1998). Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. International Journal of Cancer, 77(4), 533–537.

    CAS  Google Scholar 

  6. Aziz, N. M. (2002). Cancer survivorship research: Challenge and opportunity. Journal of Nutrition, 132(11 Suppl), 3494S–3503S.

    PubMed  CAS  Google Scholar 

  7. Azzarello, L. M., Dessureault, S., & Jacobsen, P. B. (2006). Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiology Biomarkers & Prevention, 15(1), 142–145.

    Google Scholar 

  8. Berndt. E., & Crown, W. (2002). Labor force activity in cancer patients with anemia. Quality of Life in Oncology 5, 10–13.

    Google Scholar 

  9. Berwick, M., Armstrong, B. K., Ben-Porat, L., Fine, J., Kricker, A., Eberle, C., et al. (2005). Sun exposure and mortality from melanoma. Journal of the National Cancer Institute, 97(3), 195–199.

    Article  PubMed  Google Scholar 

  10. Berwick, M., Begg, C. B., Fine, J. A., Roush, G. C., & Barnhill, R. L. (1996). Screening for cutaneous melanoma by skin self-examination. Journal of the National Cancer Institute, 88(1), 17–23.

    PubMed  CAS  Google Scholar 

  11. Boyle, D. A. (2003). Psychological adjustment to the melanoma experience. Seminars in Oncology Nursing, 19(1), 70–77.

    PubMed  Google Scholar 

  12. Breslow, A. (1970). Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Annals of Surgery, 172(5), 902–908.

    PubMed  CAS  Google Scholar 

  13. Brown, J. E., King, M. T., Butow, P. N., Dunn, S. M., & Coates, A. S. (2000). Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: An application of multilevel models. Quality of Life Research, 9(1), 75–85.

    PubMed  CAS  Google Scholar 

  14. Brown, M. L., Riley, G. F., Schussler, N., & Etzioni, R. D. Health care costs related to cancer treatment from SEER-Medicare data. Medical Care, 40(Suppl 8), 104–117.

  15. Butow, P. N., Coates, A. S., & Dunn, S. M. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology, 17(7), 2256–2263.

    PubMed  CAS  Google Scholar 

  16. Cancer survivorship—United States, 1971–2001. (2004). Morbidity and Mortality Weekly Report, 53(24), 526–529.

    Google Scholar 

  17. Carmel, S., Shani, E., & Rosenberg, L. (1994). The role of age and an expanded Health Belief Model in predicting skin cancer protective behavior. Health Education Research, 9(4), 433–447.

    PubMed  CAS  Google Scholar 

  18. Carmichael, V. E., & Wilson, K. S. (1992). Primary cutaneous malignant melanoma: Experience of the British Columbia Cancer Agency from 1972 to 1981. Canadian Journal of Surgery, 35(6), 589–597.

    CAS  Google Scholar 

  19. Chang, S., Longm, S. R., Kutikova, L., Bowman, L., Finley, D., Crown, W. H., et al. (2004). Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. Journal of Clinical Oncology, 22(17), 3524–3530.

    PubMed  Google Scholar 

  20. Cohn-Cedermark, G., Mansson-Brahme, E., Rutqvist, L. E., Larsson, O., Singnomklao, T., & Ringborg, U. (1999). Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncoloâgica, 38(5), 549–557.

    CAS  Google Scholar 

  21. Coups, E. J, & Ostroff, J. S. (2005). A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Preventive Medicine, 40(6), 702–711.

    PubMed  Google Scholar 

  22. Cristofolini, M., Zumiani, G., Boi, S., & Piscioli, F. (1986). Community detection of early melanoma. Lancet, 1(8473), 156.

    PubMed  CAS  Google Scholar 

  23. Demark-Wahnefried, W., Aziz, N. M., Rowland, J. H., & Pinto, B. M. (2005). Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. Journal of Clinical Oncology, 23(24), 5814–5830.

    PubMed  Google Scholar 

  24. Dennis, L. K., White, E., & Lee, J. A. (1993). Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes & Control, 4(2), 93–100.

    CAS  Google Scholar 

  25. Dicker, T. J., Kavanagh, G. M., Herd, R. M., Ahmad, T., McLaren, K. M., Chetty, U., et al. (1999). A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. British Journal of Dermatology, 140(2), 249–254.

    PubMed  CAS  Google Scholar 

  26. Diepgen, T. L., & Mahler, V. (2002). The epidemiology of skin cancer. British Journal of Dermatology, 146(Suppl 61), 1–6.

    PubMed  Google Scholar 

  27. DiFronzo, L. A., Wanek, L. A., Elashoff, R., & Morton, D. L. (1999). Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Annals of Surgical Oncology, 6(7), 705–711.

    PubMed  CAS  Google Scholar 

  28. Duggleby, W. F., Stoll, H., Priore, R. L., Greenwald, P., & Graham, S. (1981). A genetic analysis of melanoma-polygenic inheritance as a threshold trait. American Journal of Epidemiology, 114(1), 63–72.

    PubMed  CAS  Google Scholar 

  29. Edman, R. L., & Klaus, S. N. (2000). Is routine screening for melanoma a benign practice? Journal of the American Medical Association, 284(7), 883–886.

    PubMed  CAS  Google Scholar 

  30. English, D. R., Milne, E., & Simpson, J. A. (2006). Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia). Cancer Causes & Control, 17(1), 103–107.

    Google Scholar 

  31. Fawzy, F. I., Fawzy, N. W., Hyun, C. S., Elashoff, R., Guthrie, D., Fahey, J. L., et al. (1993). Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Archives of General Psychiatry, 50(9), 681–689.

    PubMed  CAS  Google Scholar 

  32. Fillenbaum, G. G., Pieper, C. F., Cohen, H. J., Cornoni-Huntley, J. C., & Guralnik, J. M. (2000). Comorbidity of five chronic health conditions in elderly community residents: Determinants and impact on mortality. Journal of Gerontology: Medical Sciences, 55A, M84–M89.

    Google Scholar 

  33. Fireman, B. H., Quesenberry, C. P., Somkin, C. P., Jacobson, A. S., Baer, D., West, D., et al. (1997). Cost of care for cancer in a health maintenance organization. Health Care Financing Review, 18(4), 51–76.

    PubMed  CAS  Google Scholar 

  34. Freiman, A., Yu, J., Loutfi, A., & Wang, B. (2004). Impact of melanoma diagnosis on sun-awareness and protection: Efficacy of education campaigns in a high-risk population. Journal of Cutaneous Medicine and Surgery, 8(5), 303–309.

    PubMed  Google Scholar 

  35. Friedman, R. J., Rigel, D. S., Silverman, M. K., Kopf, A. W., & Vossaert, K. A. (1991). Malignant melanoma in the 1990s: The continued importance of early detection and the role of physician examination and self-examination of the skin. CA-A Cancer Journal for Clinicians, 41(4), 201–226.

    PubMed  CAS  Google Scholar 

  36. Friedman, L. C., Webb, J. A., Bruce, S., Weinberg, A. D., & Cooper, H. P. (1995). Skin cancer prevention and early detection intentions and behavior. American Journal of Preventive Medicine, 11(1), 59–65.

    PubMed  CAS  Google Scholar 

  37. Garbe, C. (2002). A rational approach to the follow-up of melanoma patients. Recent Results in Cancer Research, 160, 205–215.

    PubMed  Google Scholar 

  38. Garbe, C., & Orfanos, C. E. (1992). Epidemiology of malignant melanoma in central Europe: Risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Research, (Suppl 2), 285–294.

  39. Garman, K. S., Pieper, C. F., Seo, P., & Cohen, H. J. (2003). Function in elderly cancer survivors depends on comorbidities. Journal of Gerontology, 58A(11), 119–1124.

    Google Scholar 

  40. Geller, A. C., Emmons, K. M., Brooks, D. R., Powers, C, Zhang, Z., Koh, H. K., et al. (2006). A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer, 107(4), 806–814.

    PubMed  Google Scholar 

  41. Geller, A. C., Koh, H. K., Miller, D. R., & Lew, R. A. (1992). Practices and beliefs concerning screening family members of patients with melanoma. Results of a survey of New England dermatologists. Journal of the American Academy of Dermatology, 26(3 Pt 2), 419–422.

    PubMed  CAS  Google Scholar 

  42. Geller, A. C., Miller, D. R., Annas, G. D., Demierre, M. F., Gilchrest, B. A., & Koh, H. K. (2002). Melanoma incidence and mortality among US whites, 1969–1999. Journal of the American Medical Association, 288(14), 1719–1720.

    PubMed  Google Scholar 

  43. Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999). The pathogenesis of melanoma induced by ultraviolet radiation. New England Journal of Medicine, 340(17), 1341–1348.

    PubMed  CAS  Google Scholar 

  44. Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003). Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist, 8(6), 541–552.

    PubMed  Google Scholar 

  45. Goggins, W. B., Finkelstein, D. M., & Tsao, H. (2001). Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer, 91(4), 874–880.

    PubMed  CAS  Google Scholar 

  46. Goldsmith, L. A., Koh, H. K., Bewerse, B. A., Reilley, B., Wyatt, S. W., Bergfeld, W. F., et al. (1996). Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. In American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, D.C., April 8–10, 1995. Journal of the American Academy of Dermatology, 35(5 Pt 1), 748–756.

    PubMed  CAS  Google Scholar 

  47. Gotay, C. C., & Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancers. Journal of the National Cancer Institute, 90(9), 656–667.

    PubMed  CAS  Google Scholar 

  48. Greer, S., Morris, T., Pettingale, K. W., & Haybittle, J. L. (1990). Psychological response to breast cancer and 15-year outcome. Lancet, 335(8680), 49–50.

    PubMed  CAS  Google Scholar 

  49. Hall, H. I., May, D. S., Lew, R. A., Koh, H. K., & Nadel, M. (1997). Sun protection behaviors of the U.S. white population. Preventive Medicine, 26(4), 401–407.

    PubMed  CAS  Google Scholar 

  50. Hay, J., Ostroff, J., Martin, A., Serle, N., Soma, S., Mujumdar, U., et al. (2005). Skin cancer risk discussions in melanoma-affected families. Journal of Cancer Education, 20(4), 240–246.

    PubMed  Google Scholar 

  51. Hewitt, M., Breen, N., & Devesa, S. (1999). Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey. Journal of the National Cancer Institute, 91(17), 1480–1486.

    PubMed  CAS  Google Scholar 

  52. Hewitt, M., Rowland, J. H., & Yancik, R. (2003). Cancer survivors in the United States: Age, health, and disability. Journals of Gerontology Series A, Biological Sciences and Medical Sciences, 58(1), 82–91.

    Google Scholar 

  53. Hillner, B. E., Kirkwood, J. M., & Agarwala, S. S. (2001). Burden of illness associated with metastatic melanoma: An audit of 100 consecutive referral center cases. Cancer, 91(9), 1814–1821.

    PubMed  CAS  Google Scholar 

  54. Honda, K., & Neugut, A. I. (2004). Associations between perceived cancer risk and established factors in a national community sample. Cancer Detection and Prevention, 28, 1–7.

    PubMed  Google Scholar 

  55. Howe, H. L., Wingo, P. A., Thun, M. J., Ries, L. A., Rosenberg, H. M., Feigal, E. G., et al. (2001). Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute, 93(11), 824–842.

    PubMed  CAS  Google Scholar 

  56. Huang, X., Soong, S., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1997). Classification of localized melanoma by the exponential survival trees method. Cancer, 79(6), 1122–1128.

    PubMed  CAS  Google Scholar 

  57. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA-A Cancer Journal for Clinicians, 55(1), 10–30.

    PubMed  Google Scholar 

  58. Keesling, B., & Friedman, H. S. (1987). Psychosocial factors in sunbathing and sunscreen use. Health Psychology, 6(5), 477–493.

    PubMed  CAS  Google Scholar 

  59. Khayat, D., Rixe, O., Martin, G., Soubrane, C., Banzet, M., Bazex, J. A., et al. (2003). Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer, 97(8), 1941–1946.

    PubMed  Google Scholar 

  60. Koh, H. K. (1991). Cutaneous melanoma. New England Journal of Medicine, 325(3), 171–182.

    Article  PubMed  CAS  Google Scholar 

  61. Koh, H. K., Geller, A. C, & Lew, R. A. (1999). Melanoma. In B. S. Kramer, J. K. Gohagen, & P. C. Prorok (Eds.), Cancer screening: Theory and practice (pp. 379–408). New York: Marcel Dekker.

    Google Scholar 

  62. Koh, H. K., Lew, R. A., & Prout, M. N. (1989). Screening for melanoma/skin cancer: Theoretic and practical considerations. Journal of the American Academy of Dermatology, 20(2 Pt 1), 159–172.

    PubMed  CAS  Google Scholar 

  63. Koh, H. K., Miller, D. R., Geller, A. C., Clapp, R. W., Mercer, M. B., & Lew, R. A. (1992). Who discovers melanoma? Patterns from a population-based survey. Journal of the American Academy of Dermatology, 26(6), 914–919.

    PubMed  CAS  Google Scholar 

  64. Kopf, A. W., Rigel, D. S., & Friedman, R. J. (1982). The rising incidence and mortality rate of malignant melanoma. Journal of Dermatologic Surgery and Oncology, 8(9), 760–761.

    PubMed  CAS  Google Scholar 

  65. Kornblith, A. B. (1998). Psychosocial adaptation of cancer survivors. In J. C. Holland (Ed.), New York: Oxford University Press.

  66. Leman, J. A., & Mac Kie, R. M. (2003). Late (>10 years) recurrence of melanoma: The Scottish experience. British Journal of Dermatology, 148(2), 372–373.

    PubMed  CAS  Google Scholar 

  67. Leventhal, H., Kelly, K., & Leventhal, E. A. (1999). Population risk, actual risk, perceived risk, and cancer control: A discussion. Journal of the National Cancer Institute. Monographs, 25, 81–85.

    PubMed  Google Scholar 

  68. Lipkus, I. M., Rimer, B. K., & Strigo, T. S. (1996). Relationships among objective and subjective risk for breast cancer and mammography stages of change. Cancer Epidemiology Biomarkers and Preventions, 5(12), 1005–1011.

    CAS  Google Scholar 

  69. MacKie, R. M., & Hole, D. (1992). Audit of public education campaign to encourage earlier detection of malignant melanoma. British Medical Journal, 304(6833), 1012–1015.

    PubMed  CAS  Google Scholar 

  70. Manne, S., Fasanella, N., Connors, J., Floyd, B., Wang, H., & Lessin, S. (2004). Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: Prevalence and predictors. Preventive Medicine, 39(1), 36–47.

    PubMed  Google Scholar 

  71. Manne, S., & Lessin, S. (2006). Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. Journal of Behavioral Medicine, 29(5), 419–434.

    PubMed  Google Scholar 

  72. Margolis, D. J., Halpern, A. C., Rebbeck, T., Schuchter, L., Barnhill, R. L., Fine, J., et al. (1998). Validation of a melanoma prognostic model. Archives of Dermatology, 134(12), 1597–1601.

    PubMed  CAS  Google Scholar 

  73. Masback, A., Westerdahl, J., Ingvar, C., Olsson, H., & Jonsson, N. (1997). Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations. Cancer, 79(2), 275–283.

    PubMed  CAS  Google Scholar 

  74. McBride, C. M., Emmons, K. M., & Lipkus, I. M. (2003). Understanding the potential of teachable moments: The case of smoking cessation. Health Education Research, 18(2), 156–170.

    PubMed  CAS  Google Scholar 

  75. McKenna, D. B., Stockton, D., Brewster, D. H., & Doherty, V. R. (2003). Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: A population-based retrospective cohort study in Scotland. British Journal of Cancer, 88(1), 74–78.

    PubMed  CAS  Google Scholar 

  76. McPherson, M., Elwood, M., English, D. R., Baade, P. D., Youl, P. H., & Aitken, J. F. (2006). Presentation and detection of invasive melanoma in a high-risk population. Journal of the American Academy of Dermatology, 54(5), 783–792.

    PubMed  Google Scholar 

  77. Miller, D. R., Geller, A. C., Wyatt, S. W., Halpern, A., Howell, J. B., Cockerell, C., et al. (1996). Melanoma awareness and self-examination practices: Results of a United States survey. Journal of the American Academy of Dermatology, 34(6), 962–970.

    PubMed  CAS  Google Scholar 

  78. Miller, D. L., & Weinstock, M. A. (1994). Nonmelanoma skin cancer in the United States: Incidence. Journal of the American Academy of Dermatology, 30(5 Pt 1), 774–778.

    PubMed  CAS  Google Scholar 

  79. Molassiotis, A., Van Den Akker, O. B., Milligan, D. W., & Goldman, J. M. (1997). Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. Journal of Psychosomatic Research, 42(3), 275–285.

    PubMed  CAS  Google Scholar 

  80. National Cancer Institute (2002). US estimated complete prevalence counts on 1/1/2002 first malignant cancer only by cancer site, sex, and race. CanQuest Hosting Service, 2002. (Ed.). Available at http://canques.seer.cancer.gov.

  81. NIH Consensus conference (1992). Diagnosis and treatment of early melanoma. Journal of the American Medical Association, 268(10), 1314–1319.

    Google Scholar 

  82. Ostroff, J., Garland, J., Moadel, A., Fleshner, N., Hay, J., Cramer, L., et al. (2000). Cigarette smoking patterns in patients after treatment of bladder cancer. Journal of Cancer Education, 15(2), 86–90.

    PubMed  CAS  Google Scholar 

  83. Pakilit, A. T., Kahn, B. A., Petersen, L., Abraham, L. S., Greendale, G. A., & Ganz, P. A. (2001). Making effective use of tumor registries for cancer survivorship research. Cancer, 92(5), 1305–1314.

    PubMed  CAS  Google Scholar 

  84. Pehamberger, H., Binder, M., Knollmayer, S., & Wolff, K. (1993). Immediate effects of a public education campaign on prognostic features of melanoma. Journal of the American Academy of Dermatology, 29(1), 106–109.

    PubMed  CAS  Google Scholar 

  85. Pinto, B. M., Eakin, E., & Maruyama, N. C. (2000). Health behavior changes after a cancer diagnosis: What do we know and where do we go from here? Annals of Behavioral Medicine, 22(1), 38–52.

    Article  PubMed  CAS  Google Scholar 

  86. Ponder, M., Lee, J., Green, J., & Richards, M. (1996). Family history and perceived vulnerability to some common diseases: A study of young people and their parents. Journal of Medical Genetics, 33(6), 485–492.

    PubMed  CAS  Google Scholar 

  87. Rhee, J. S., Matthews, B. A., Neuburg, M., Smith, T. L., Burzynski, M., & Nattinger, A. B. (2004). Quality of life and sun-protective behavior in patients with skin cancer. Archives of Otolaryngology, Head & Neck Surgery, 130(2), 141–146.

    Google Scholar 

  88. Rhodes, A. R. (1995). Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer, 75(Suppl 2), 613–636.

    PubMed  CAS  Google Scholar 

  89. Rhodes, A. R., Weinstock, M. A., Fitzpatrick, T. B., Mihm, M. C., Jr., & Sober, A. J. (1987). Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. Journal of the American Medical Association, 258(21), 3146–3154.

    PubMed  CAS  Google Scholar 

  90. Robison, L. L. (2004). Cancer survivorship: Unique opportunities for research. Cancer Epidemiology Biomarkers & Preventions, 13(7), 1093.

    Google Scholar 

  91. Robinson, J. K., Rigel, D. S., & Amonette, R. A. (1998). What promotes skin self-examination? Journal of the American Academy of Dermatology, 38(5 Pt 1), 752–757.

    PubMed  CAS  Google Scholar 

  92. Rogentine, G. N., Jr., van Kammen, D. P., Fox, B. H., Docherty, J. P., Rosenblatt, J. E., Boyd, S. C., et al. (1979). Psychological factors in the prognosis of malignant melanoma: A prospective study. Psychosomatic Medicine, 41(8), 647–655.

    PubMed  Google Scholar 

  93. Roush, G. C., McKay, L., & Holford, T. R. (1992). A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer, 69(7), 1714–1720.

    PubMed  CAS  Google Scholar 

  94. Sahin, S., Rao, B., Kopf, A. W., Lee, E., Rigel, D. S., Nossa, R., et al. (1997). Predicting ten-year survival of patients with primary cutaneous melanoma: Corroboration of a prognostic model. Cancer, 80(8), 1426–1431.

    PubMed  CAS  Google Scholar 

  95. Salasche, S. J. (2000). Epidemiology of actinic keratoses and squamous cell carcinoma. Journal of the American Academy of Dermatology, 42(1 Pt 2), 4–7.

    PubMed  CAS  Google Scholar 

  96. Schag, C. A. C., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, S. S. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127–141.

    PubMed  CAS  Google Scholar 

  97. Schuchter, L., Schultz, D. J., Synnestvedt, M., Trock, B. J., Guerry, D., Elder, D. E., et al. (1996). A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Annals of Internal Medicine, 125(5), 369–375.

    PubMed  CAS  Google Scholar 

  98. Scotto, J., Pitcher, H., & Lee, J. A. (1991). Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. International Journal of Cancer, 49(4), 490–497.

    CAS  Google Scholar 

  99. Senior, V., Marteau, T. M., & Weinman, J. (2000). Impact of genetic testing on causal models of heart disease and arthritis: An analogue study. Psychology Health, 14, 1077–1088.

    Google Scholar 

  100. Sigurdardottir, V., Bolund, C., & Sullivan, M. (1996). Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy. Acta Oncoloâgica, 35(2), 149–158.

    CAS  Google Scholar 

  101. Soong, S. J., Harrison, R. A., McCarthy, W. H., Urist, M. M., & Balch, C. M. (1998). Factors affecting survival following local, regional, or distant recurrence from localized melanoma. Journal of Surgical Oncology, 67(4), 228–233.

    PubMed  CAS  Google Scholar 

  102. Soong, S. J., Shaw, H. M., Balch, C. M., McCarthy, W. H., Urist, M. M., & Lee, J. Y. (1992). Predicting survival and recurrence in localized melanoma: A multivariate approach. World Journal of Surgery, 16(2), 191–195.

    PubMed  CAS  Google Scholar 

  103. Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2(8668), 888–891.

    PubMed  CAS  Google Scholar 

  104. Stavraky, K. M., Donner, A. P., Kincade, J. E., & Stewart, M. A. (1988). The effect of psychosocial factors on lung cancer mortality at one year. Journal of Clinical Epidemiology, 41(1), 75–82.

    PubMed  CAS  Google Scholar 

  105. Surveillance, Epidemiology, and End Results (SEER) Program (2003). SEERStat Database: Incidence—SEER 9 Regulations. Bethesda, Maryland: National Cancer Institute, Division of Cancer Control and Population Sciences. Available at http://www.seer.cancer.gov.

  106. Theobald, T., Marks, R., Hill, D., & Dorevitch, A. (1991). “Goodbye sunshine”: Effects of a television program about melanoma on beliefs, behavior, and melanoma thickness. Journal of the American Academy of Dermatology, 25(4), 717–723.

    Article  PubMed  CAS  Google Scholar 

  107. Trask, P. C., Paterson, A. G., Esper, P., Pau, J., & Redman, B. (2004). Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology, 13(8), 526–536.

    PubMed  Google Scholar 

  108. Trask, P. C., Paterson, A. G., Hayasaka, S., Dunn, R. L., Riba, M., & Johnson, T. (2001). Psychosocial characteristics of individuals with non-stage IV melanoma. Journal of Clinical Oncology, 19(11), 2844–2850.

    PubMed  CAS  Google Scholar 

  109. Tsao, H., Rogers, G. S., & Sober, A. J. (1998). An estimate of the annual direct cost of treating cutaneous melanoma. Journal of the American Academy of Dermatology, 38(5 Pt 1), 669–680.

    PubMed  CAS  Google Scholar 

  110. Tucker, M. A., Fraser, M. C., Goldstein, A. M., Elder, D. E., Guerry, D. T., & Organic, S. M. (1993). Risk of melanoma and other cancers in melanoma-prone families. Journal of Investigative Dermatology, 100(3), 350S–355S.

    PubMed  CAS  Google Scholar 

  111. Weinstein, N. D. (1984). Why it won’t happen to me: Perceptions of risk factors and susceptibility. Health Psychology, 3(5), 431–457.

    PubMed  CAS  Google Scholar 

  112. Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10(5), 481–500.

    PubMed  CAS  Google Scholar 

  113. Weinstock, M. A. (2000). Early detection of melanoma. Journal of the American Medical Association, 284(7), 886–889.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Dermatology Service, Memorial Sloan-Kettering Cancer Center, 160 East 53rd Street 2nd Floor, New York, NY, 10022, USA

    Susan A. Oliveria, Maureen K. Heneghan & Allan C. Halpern

  2. Department of Psychiatry and Behavioral Sciences, Psychiatry Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Jennifer L. Hay

  3. Department of Dermatology, Boston University School of Medicine, Boston, MA, USA

    Alan C. Geller

  4. Department of Epidemiology and Biostatistics, Boston University School of Public Health, Boston, MA, USA

    Alan C. Geller

  5. Office of Physician-in-Chief, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Mary S. McCabe

Authors
  1. Susan A. Oliveria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer L. Hay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan C. Geller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maureen K. Heneghan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mary S. McCabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Allan C. Halpern
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan A. Oliveria.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oliveria, S.A., Hay, J.L., Geller, A.C. et al. Melanoma survivorship: research opportunities. J Cancer Surviv 1, 87–97 (2007). https://doi.org/10.1007/s11764-007-0009-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-007-0009-y

Keywords

Search

Navigation